Literature DB >> 6415489

Diazepam antagonizes GABA- and muscimol-induced changes of acetylcholine release in slices of guinea-pig cerebral cortex.

S Tanganelli, C Bianchi, L Beani.   

Abstract

The acetylcholine (ACh) release was studied in superfused, electrically-stimulated slices of guinea-pig cerebral cortex. Muscimol and 4,5,6,7-tetrahydroisoxazolo (5-4-c)-pyridin-3-ol (THIP), as well as exogenous GABA, reduced the electrically-evoked ACh release and enhanced its spontaneous outflow. Picrotoxin antagonized these effects. In addition, picrotoxin and ethanolamine-O-sulphate (EOS) caused opposite changes in transmitter outflow, suggesting the existence of an exogenous GABAergic control on the cholinergic nerve endings. Neither flurazepam 6.6 X 10(-6)--3.3 X10(-5) mol/l nor diazepam 3.3 X 10(-6)--3.3 X 10(-5) mol/l by themselves affected ACh release. Diazepam prevented GABA-, muscimol- and EOS-induced changes in spontaneous and 1 Hz-evoked outflow. Ro 15-1788 3.3 X 10(*-6) mol/l abolished diazepam antagonism vs exogenous GABA. The ineffectiveness of flurazepam and diazepam on normal release (i.e. the lack of potentiation vs the endogenous GABAergic control) supports the view that "synaptic" GABA receptors acting upon the cholinergic nerve endings are not coupled with Benzodiazepine receptors. The unexpected diazepam antagonism vs exogenous GABA and GABA-like compounds can be explained with an unusual Diazepam negative cooperation with "extrasynaptic" GABA receptors, possibly present on the cholinergic terminals. Thus, the rule of benzodiazepine-GABA synergism does not seem always tenable, at least at certain pre-synaptic sites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415489     DOI: 10.1007/BF00647835

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Effects of some anti-epileptic drugs on brain acetylcholine.

Authors:  C Bianchi; L Beani; A Bertelli
Journal:  Neuropharmacology       Date:  1975 May-Jun       Impact factor: 5.250

2.  Is GABA release modulated by presynaptic receptors?

Authors:  P R Mitchell; I L Martin
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

3.  Effects of flurazepam on amino acid-evoked responses recorded from the lobster muscle and the frog spinal cord.

Authors:  A Nistri; A Constanti
Journal:  Neuropharmacology       Date:  1978-02       Impact factor: 5.250

Review 4.  Action of the benzodiazepines on the cholinergic system.

Authors:  S Consolo; S Garattini; H Ladinsky
Journal:  Adv Biochem Psychopharmacol       Date:  1975

5.  K-Stimulated acetylcholine release: inhibition by several barbiturates and chloral hydrate but not by ethanol, chlordiazepoxide or 11-OH-delta9-tetrahydrocannabinol.

Authors:  J A Richter; L L Werling
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

Review 6.  GABA-benzodiazepine-barbiturate receptor interactions.

Authors:  R W Olsen
Journal:  J Neurochem       Date:  1981-07       Impact factor: 5.372

7.  A novel GABA receptor modulates stimulus-induced glutamate release from cortico-striatal terminals.

Authors:  R Mitchell
Journal:  Eur J Pharmacol       Date:  1980-10-03       Impact factor: 4.432

8.  GABAergic regulation of the substantia innominata-cortical cholinergic pathway.

Authors:  P L Wood; J Richard
Journal:  Neuropharmacology       Date:  1982-10       Impact factor: 5.250

9.  GABA autoreceptors are not coupled to benzodiazepine receptors in rat cerebral cortex.

Authors:  M J Brennan
Journal:  J Neurochem       Date:  1982-01       Impact factor: 5.372

10.  Noradrenaline inhibition of acetylcholine release from guinea-pig brain.

Authors:  L Beani; C Bianchi; A Giacomelli; F Tamberi
Journal:  Eur J Pharmacol       Date:  1978-03-15       Impact factor: 4.432

View more
  1 in total

1.  GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines.

Authors:  A Agmo; R Pruneda; M Guzmán; M Gutiérrez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.